Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if the combination of Avastin
(bevacizumab) and Tykerb (lapatinib) can help to control ependymoma in pediatric patients.
The safety of this drug combination will also be studied.
Phase:
Phase 2
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborator:
CERN Foundation - Collaborative Ependymoma Research Network